blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2937359

EP2937359 - CHROMATOGRAPHIC METHOD FOR ISOLATING AND PURIFYING HIGH-PURITY RECOMBINED HUMAN SERUM ALBUMIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.04.2019
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  11.05.2018
FormerGrant of patent is intended
Status updated on  03.01.2018
FormerExamination is in progress
Status updated on  03.03.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
WUHAN HEALTHGEN BIOTECHNOLOGY CORP
No.666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan
Hubei 430079 / CN
[2015/44]
Inventor(s)01 / YANG, Daichang
666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan Hubei 430079 / CN
02 / SHI, Bo
666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan Hubei 430079 / CN
03 / SHI, Qianni
666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan Hubei 430079 / CN
04 / OU, Jiquan
666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan Hubei 430079 / CN
05 / LIU, Jingru
666 Gaoxin Avenue
East Lake High-Tech Development Zone
Wuhan Hubei 430079 / CN
 [2015/44]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2018/24]
Former [2015/44]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date13864364.809.05.2013
[2015/44]
WO2013CN75405
Priority number, dateCN20121055939021.12.2012         Original published format: CN201210559390
[2015/44]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014094406
Date:26.06.2014
Language:ZH
[2014/26]
Type: A1 Application with search report 
No.:EP2937359
Date:28.10.2015
Language:EN
[2015/44]
Type: B1 Patent specification 
No.:EP2937359
Date:13.06.2018
Language:EN
[2018/24]
Search report(s)International search report - published on:CN26.06.2014
(Supplementary) European search report - dispatched on:EP03.05.2016
ClassificationIPC:C07K1/18, C07K14/765
[2015/44]
CPC:
C07K14/765 (EP,CN,US); Y02A50/30 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:CHROMATOGRAFISCHES VERFAHREN ZUR ISOLIERUNG UND REINIGUNG VON HOCHREINEM REKOMBINANTEN MENSCHLICHEN SERUMALBUMIN[2015/44]
English:CHROMATOGRAPHIC METHOD FOR ISOLATING AND PURIFYING HIGH-PURITY RECOMBINED HUMAN SERUM ALBUMIN[2015/44]
French:MÉTHODE CHROMATOGRAPHIQUE D'ISOLEMENT ET DE PURIFICATION DE SÉRUMALBUMINE HUMAINE RECOMBINÉE DE PURETÉ ÉLEVÉE[2015/44]
Entry into regional phase25.06.2015Translation filed 
25.06.2015National basic fee paid 
25.06.2015Search fee paid 
25.06.2015Designation fee(s) paid 
25.06.2015Examination fee paid 
Examination procedure20.10.2014Request for preliminary examination filed
International Preliminary Examining Authority: CN
25.06.2015Examination requested  [2015/44]
17.11.2016Amendment by applicant (claims and/or description)
01.03.2017Despatch of a communication from the examining division (Time limit: M04)
04.07.2017Reply to a communication from the examining division
19.09.2017Despatch of a communication from the examining division (Time limit: M02)
13.10.2017Reply to a communication from the examining division
04.01.2018Communication of intention to grant the patent
11.04.2018Fee for grant paid
11.04.2018Fee for publishing/printing paid
11.04.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18174112.5  / EP3398964
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.03.2017
Opposition(s)14.03.2019No opposition filed within time limit [2019/21]
Fees paidRenewal fee
25.06.2015Renewal fee patent year 03
23.05.2016Renewal fee patent year 04
26.05.2017Renewal fee patent year 05
04.05.2018Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.05.2013
AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
MC13.06.2018
MK13.06.2018
MT13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
PT15.10.2018
[2022/31]
Former [2021/34]HU09.05.2013
AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
MC13.06.2018
MT13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
PT15.10.2018
Former [2021/32]HU09.05.2013
AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
MC13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
PT15.10.2018
Former [2020/29]AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
MC13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
PT15.10.2018
Former [2020/07]AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
MC13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/51]AL13.06.2018
AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/26]AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SI13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/12]AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SK13.06.2018
SM13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/10]AT13.06.2018
CY13.06.2018
CZ13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
SK13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/09]CY13.06.2018
EE13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/08]CY13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
IS13.10.2018
Former [2019/03]CY13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
NL13.06.2018
RS13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
Former [2018/52]CY13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
RS13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
GR14.09.2018
Former [2018/51]CY13.06.2018
HR13.06.2018
LT13.06.2018
LV13.06.2018
RS13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
Former [2018/50]CY13.06.2018
HR13.06.2018
LT13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
Former [2018/49]CY13.06.2018
LT13.06.2018
SE13.06.2018
BG13.09.2018
NO13.09.2018
Former [2018/47]LT13.06.2018
NO13.09.2018
Documents cited:Search[A]US5917022  (DAVIES JEFFREY RAYMOND [AU]) [A] 1-11* the whole document *;
 [Y]WO2005003152  (AKZO NOBEL NV [NL], et al) [Y] 1-11 * the whole document *;
 [A]CN101260145  (BEIJING WEIMING FUYUAN GENE PH [CN]) [A] 1-11 * the whole document *;
 [Y]WO2012083580  (HEALTHGEN BIOTECHNOLOGY CO LTD [CN], et al) [Y] 1-11 * the whole document * * page 13, lines 1-3; example 7; claim - *;
 [Y]  - LIN M F ET AL, "Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by nonflammable solvents", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 816, no. 1-2, ISSN 1570-0232, (20050225), pages 167 - 174, (20050225), XP027626884 [Y] 1-11 * the whole document *
 [Y]  - BURNOUF T ET AL, "Affinity chromatography in the industrial purification of plasma proteins for therapeutic use", JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, AMSTERDAM, NL, (20011030), vol. 49, no. 1-3, doi:10.1016/S0165-022X(01)00221-4, ISSN 0165-022X, pages 575 - 586, XP002353092 [Y] 1-11 * the whole document * * page 580 - page 581 *

DOI:   http://dx.doi.org/10.1016/S0165-022X(01)00221-4
 [A]  - BELEW M ET AL, "Purification of Recombinant Human Serum Albumin (rHSA) Produced by Genetically Modified Pichia Pastoris", SEPARATION SCIENCE AND TECHNOLOGY, DEKKER, NEW YORK, NY, US, vol. 43, no. 13, doi:10.1080/01496390802221857, ISSN 0149-6395, (20080831), pages 3134 - 3153, (20080801), XP008169071 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1080/01496390802221857
International search[A]WO9015617  (GREEN CROSS CORP [JP]);
 [A]CN101665798  (ZHEJIANG DEQING ANPING BIOLOGY);
 [A]CN102127164  (WUHAN HEALTHGEN BIOTECHNOLOGY CO LTD);
 [A]CN102190722  (SHANGHAI ANRUITE BIOMEDICAL TECHNOLOGY CO LTD);
 [X]CN102532254  (WUHAN HEALTHGEN BIOTECHNOLOGY CO LTD)
by applicantEP0683233
 US5612196
 WO0044772
    - LATTA, M. ET AL., BIO/TECHNOLOGY, (1987), vol. 5, pages 1309 - 1314
    - SAUNDERS, C. W. ET AL., J. BACTERIOL., (1987), vol. 169, pages 2917 - 2925
 CN20051019084
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.